President Donald Trump signed an executive order on Saturday directing federal health agencies to accelerate research and regulatory approval for psychedelic compounds being studied as treatments for mental health disorders. The Oval Office ceremony included an unlikely participant: popular podcaster and occasional Trump critic Joe Rogan.
Focus on Veteran Mental Health Crisis
The order specifically targets treatments for veterans struggling with anxiety, depression, and post-traumatic stress disorder (PTSD). President Trump stated the action applies to certain drugs, including psychedelics, that are already in advanced clinical trials. "Today's order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives," Trump said during the signing.
Trump highlighted Ibogaine, a psychedelic substance used in some countries for addiction and PTSD treatment, noting his administration would "open the pathway" for its inclusion under the Right to Try Act. This 2018 law allows terminally ill patients to access investigational treatments not yet fully approved by the Food and Drug Administration (FDA). The move comes amid a persistent mental health crisis among service members. According to the Pentagon's latest annual suicide report, 471 U.S. service members died by suicide in 2024, with 1,515 attempts reported.
Rogan's Role and Administration's Fast-Track Plan
Joe Rogan, whose podcast frequently discusses alternative therapies, said he had sent information about psychedelic treatments to the president after learning about them. "The text message that came back: 'Sounds great. Do you want FDA approval? Let's do it.' Literally that quick," Rogan recounted at the White House. This collaboration is notable given Rogan's recent criticism of the administration's military operations, such as the U.S. strikes in Iran.
FDA Commissioner Martin Makary outlined the administration's expedited review process at the ceremony. "Under this new program, drugs can get approved in weeks, not a year or year plus, if they are in line with our national priorities," Makary said. He noted the program currently has 18 vouchers for fast-tracking treatments and will add three more next week, calling the effort an urgent response to an "unmet public health need."
The event was also attended by Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services head Mehmet Oz. The signing represents a continued push by the Trump administration to position itself on healthcare innovation, following other moves like nominating a public health veteran to lead the CDC.
Broader Political and Policy Context
During the event, President Trump also promoted his "Most Favored Nation" drug pricing initiative and the TrumpRX.com platform, touting his administration's efforts to lower pharmaceutical costs. The executive order fits into a pattern of the administration using executive action to advance policy priorities, similar to previous orders on medical research issued during campaign cycles.
The focus on mental health treatment alternatives arrives as the administration faces scrutiny over other substance-related policies, including political pressure on research funding for alcohol, the nation's leading substance-related killer. By aligning with a cultural figure like Rogan and emphasizing veteran care, the White House appears to be bridging political and cultural divides on a contentious issue while addressing a critical healthcare challenge.
